TGen Clinical Trial Shows Substantial Benefit in Treating Pancreatic Cancer

TGen-HonorHealth clinical trial shows
tumor shrinkage in 71% of patients with
late-stage pancreatic cancer.*

Read Full Press Release

 

In the event of a cancer diagnosis, genomic sequencing is what can help your clients have the best shot at beating their cancer. GTL’s Precision CareTM Cancer Insurance with access to TGen’s genomic sequencing services was designed to fill this exact need.

View Website

Order Supplies On GTLink
 

#goldencareagent
#gtl
#tgen